latest update:
[TrialBase DB]

trial summary · NCT06791057

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Trial record from the TrialBase DB dataset, status RECRUITING, condition Advanced Lung Cancer, sponsored by Massachusetts General Hospital. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06791057phase —enrollment 420start 2026-11-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Dyspnea, or breathlessness, is one of the most common and distressing symptoms experienced by patients with advanced lung cancer. The purpose of this multi-site trial is to test the effectiveness of a dyspnea intervention (called BREEZE+) that includes three brief nurse-delivered sessions and access to a digital health app that teaches and reinforces patients' use of skills for managing and coping with this highly debilitating symptom. This study will lay the groundwork for a follow-up pragmatic implementation trial integrating BREEZE+ into usual oncology care for patients with advanced lung cancer experiencing dyspnea.

Source record: https://clinicaltrials.gov/study/NCT06791057

Facts

registry idNCT06791057
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionAdvanced Lung Cancer
sponsorMassachusetts General Hospital
sponsor classOTHER
enrollment420
start date2026-11-01
primary completion2030-12-31
completion2031-06-30
results postednot reported

Conditions

  • Advanced Lung Cancer
  • Dyspnea

Interventions

  • Dyspnea Intervention
  • Enhanced Usual Care

Countries

  • United States

Intervention types: BEHAVIORAL

Work with this record